Skip to Content

FDA Sends Warning Letters for Dacogen and Fosrenol

ROCKVILLE, Md., Nov. 16,2009--The FDA has posted on its website warning letters it sent to Eisai, Inc. for Dacogen and to Shire Development Inc. for Fosrenol. Both letters mention misleading information regarding the marketing of the two drugs.

Posted: November 2009

View comments